Get startedLog in
    Picture of Biorestorative Therapies logo

    BRTX — Biorestorative Therapies News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: BioRestorative Therapies Announces FDA Clearance Of Phase 2 BRTX-100 Clinical Study Protocol Amendment

    Picture of Biorestorative Therapies logoBiorestorative Therapies
    16/04/2024 13:35
    April 16 (Reuters) - BioRestorative Therapies Inc
 BRTX.O :
    * BIORESTORATIVE THERAPIES ANNOUNCES FDA CLEARANCE OF PHASE
2
BRTX-100 CLINICAL STUDY PROTOCOL AMENDMENT
    * BIORESTORATIVE THERAPIES ANNOUNCES FDA CLEARANCE OF PHASE
2
BRTX-100 CLINICAL STUDY PROTOCOL AMENDMENT
    * BIORESTORATIVE THERAPIES INC - PROTOCOL AMENDMENT REMOVES
SALINE
INJECTION IN CONTROL ARM OF STUDY AND REPLACES IT WITH A SHAM
INJECTION

Source text for Eikon:  ID:nGNX5WkfGT 
Further company coverage:  BRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Biorestorative Therapies

    See all news